AlloSource's president and CEO, Tom Cycyota, plans to retire after leading the biologics company for 22 years.
Mr. Cycyota stepped into the role in 2000 and helped the company provide more than 3 million allografts for surgical procedures, according to an Aug. 2 news release. He will remain in his role until a successor is appointed.
AlloSource has more than 200 products for applications including spinal fusions, rotator cuff repairs and reconstruction surgery.